Retatrutide
The most powerful weight loss solution available, with 24% average weight loss in trials.
Read the full Retatrutide profileThe newest triple-agonist against the most established GLP-1 — a plain-English look at how retatrutide and semaglutide differ in action and dosing.
This page compares the same profile fields for both. It does not decide which is better, recommend either compound, or determine whether switching or combining them is appropriate.
The most powerful weight loss solution available, with 24% average weight loss in trials.
Read the full Retatrutide profileTake control of your appetite and transform your body with proven science.
Read the full Semaglutide profileRetatrutide is a triple-action peptide that tells your body to eat less, burn more calories through glucagon, and improve blood sugar control, all in one molecule for powerful weight and metabolic effects.
Semaglutide is an FDA-approved GLP-1 receptor agonist that has transformed treatment of obesity and type 2 diabetes. It works by mimicking the hormone GLP-1 to reduce appetite, slow stomach emptying, and improve insulin sensitivit...
Still in clinical trials. GI side effects are common but manageable.
Investigational drug - not yet approved. Titrate slowly to minimize side effects. Do not mix in the same syringe as other peptides. Inject GLP-1s on their own.
FDA-approved with well-characterized side effects. GI issues are common but manageable.
Contraindicated in medullary thyroid cancer or MEN 2 syndrome. May cause pancreatitis. Do not mix in the same syringe as other peptides. Inject GLP-1s on their own.
Start at 0.5 mg weekly, titrate to 2.5-5 mg weekly
weekly
12 weeks on, 12 weeks off (per clinical trials)
Slow titration is key - increase dose every 4 weeks to minimize GI effects
Injection: Start 0.25 mg weekly, titrate to 1-2.4 mg weekly. Oral: Start 3 mg daily, up to 14 mg daily
weekly
Ongoing as prescribed
Titrate slowly over months to minimize GI side effects; take oral on empty stomach
The rows above pull from the live peptide profile data used across The Peptide App. Use the comparison to spot differences in documented profile context, titration notes, and safety flags. Missing data remains missing rather than being inferred.
Retatrutide is summarized as: The most powerful weight loss solution available, with 24% average weight loss in trials. Semaglutide is summarized as: Take control of your appetite and transform your body with proven science.
Comparison questions are personal and context-dependent, so these answers stay educational instead of recommending a protocol.
Retatrutide and Semaglutide are distinct compounds and can differ in mechanism, documented profile context, titration notes, evidence, and safety flags. The comparison table shows the same stored fields side by side and leaves unavailable information blank.
There is no universal answer, and this page does not rank or recommend either compound. A licensed professional can interpret the evidence, product status, and individual context; this page is only a structured research comparison.
Combining peptides can change dosing complexity and risk. This comparison is not medical advice, and it should not be used to start, stop, or combine protocols. A licensed professional is the right person to evaluate whether any combination is appropriate.
This comparison is for research and educational purposes. It does not diagnose, treat, prescribe, or replace guidance from a licensed professional. Always follow the instructions provided with your product.
Keep dose timing, reminders, and protocol notes in one place after you decide what you want to track.
Open either peptide profile, browse the peptide library, or compare another pair.